MaxWell Biosystems Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • MaxWell Biosystems's estimated annual revenue is currently $8.1M per year.(i)
  • MaxWell Biosystems's estimated revenue per employee is $155,000

Employee Data

  • MaxWell Biosystems has 52 Employees.(i)
  • MaxWell Biosystems grew their employee count by 21% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$7.9M5116%N/AN/A
#2
$8.1M5221%N/AN/A
Add Company

MaxWell Biosystems provides next generation high-content electrophysiology platforms to facilitate detailed investigation of cells in vitro. MaxOne and MaxTwo are microelectrode array systems ideally suited to phenotype human iPSC-derived neuronal disease models and screen pharmacological compounds. A high electrode density and high signal-to-noise ratio ensure that every single cell can be captured and analyzed, providing detailed insights into neuronal network functionality and maturity.

keywords:N/A

N/A

Total Funding

52

Number of Employees

$8.1M

Revenue (est)

21%

Employee Growth %

N/A

Valuation

N/A

Accelerator

MaxWell Biosystems News

2022-04-19 - Microelectrode Arrays (MEAs) Market Size, Outlook And ...

MaxWell Biosystems, Axion Biosystems, Multi Channel Systems MCS GmbH, Med64, 3Brain. Microelectrode Arrays (MEAs) Market Segmentation:.

2022-04-17 - Global Micro Electrode Array Market 2022 Business Strategies ...

MaxWell Biosystems; Axion Biosystems; 3Brain; Multi Channel Systems MCS GmbH; Med64 (former AlphaMED). The following are the essential...

2022-03-22 - Researchers Build Neural Networks With Actual Neurons

These cells were plated onto a high-density multielectrode array from Maxwell Biosystems. Once deposited and properly cultured in the lab,...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$6.8M52-15%N/A
#2
$6.8M5273%N/A
#3
N/A5218%N/A
#4
$10M5383%N/A
#5
$6.3M54-2%N/A